Analysts expect Contineum Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 8.39 M | 6.03 M | 7.67 M | 0.00 | 0.00 | 0.00 | 7.52 M | 0.00 | 0.00 | -414,115.99 | 6.35 M | -444,885.81 | -1.11 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 7.06 M | 5.22 M | 6.29 M | 0.00 | 0.00 | 0.00 | 6.47 M | 0.00 | 0.00 | -456,096.79 | 5.39 M | -502,796.79 | -1.19 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 7.72 M | 5.62 M | 6.98 M | 0.00 | 0.00 | 0.00 | 6.99 M | 0.00 | 0.00 | -435,106.39 | 5.87 M | -473,841.30 | -1.15 M |
Analysts expect Contineum Therapeutics, Inc. to report earnings per share of -0.44 for Q3 26, against a range of -0.48 to -0.40. The most recent reported quarter, Q2 26, came in at -0.40, a 4.8% beat against the -0.42 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.40 | -0.56 | -0.62 | -0.62 | -0.45 | -0.49 | -0.39 | -0.40 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.37 | -0.44 | -0.50 | -0.43 | -0.45 | -0.33 | -0.47 | -0.39 | -0.40 | -0.44 | -0.43 | -0.50 | -0.50 | -0.46 | -0.45 | -0.46 | ||||||||||
| Low Estimate | -0.41 | -0.46 | -0.58 | -0.47 | -0.55 | -0.39 | -0.53 | -0.45 | -0.48 | -0.48 | -0.49 | -0.56 | -0.54 | -0.54 | -0.49 | -0.50 | ||||||||||
| Consensus Estimate | -0.39 | -0.45 | -0.54 | -0.45 | -0.50 | -0.36 | -0.50 | -0.42 | -0.44 | -0.46 | -0.46 | -0.53 | -0.52 | -0.50 | -0.47 | -0.48 |
Pull Wall Street consensus for Contineum Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CTNM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CTNM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CTNM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();